Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Multiple Sclerosis

Free Subscription 16.01.2023 1 Hum Immunol 2 J Neurol 1 J Neurol Neurosurg Psychiatry 2 Mult Scler 2 Nat Med 2 Nat Rev Neurol 1 Neurology 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Hum Immunol

1. YEON KIM S, Kim Y, Kim SH, Han SM, et al
   Antigen-independent IL-17A production by bystander-activated CD4(+)IL-1R1(+) cells in patients with multiple sclerosis.
   Hum Immunol. 2023 Jan 4:S0198-8859(22)00253-1. doi: 10.1016/j.humimm.2022.
   PubMed         Abstract available
   
   

   
   J Neurol

2. CAGOL A, Fuertes NC, Stoessel M, Barakovic M, et al
   Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
   J Neurol. 2023 Jan 10. doi: 10.1007/s00415-022-11535.
   PubMed         Abstract available
   
   
3. DAVION JB, Jougleux C, Lopes R, Leclerc X, et al
   Relation between retina, cognition and brain volumes in MS: a consequence of asymptomatic optic nerve lesions.
   J Neurol. 2023;270:240-249.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

4. TOOROP AA, van Kempen ZLE, Steenhuis M, Nielsen J, et al
   Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2023 Jan 13:jnnp-2022-330467.
   PubMed         Abstract available
   
   

   
   Mult Scler

5. ANDERSON J, Sumowski JF
   Towards a phenotypic understanding of multiple sclerosis depression.
   Mult Scler. 2023 Jan 12:13524585221148143. doi: 10.1177/13524585221148143.
   PubMed        
   
   
6. BRALEY TJ, Shieu MM, Zaheed AB, Dunietz GL, et al
   Pathways between multiple sclerosis, sleep disorders, and cognitive function: Longitudinal findings from The Nurses' Health Study.
   Mult Scler. 2023 Jan 12:13524585221144215. doi: 10.1177/13524585221144215.
   PubMed         Abstract available
   
   

   
   Nat Med

7. FOSSATI V, Peruzzotti-Jametti L, Pluchino S
   A neural stem-cell treatment for progressive multiple sclerosis.
   Nat Med. 2023 Jan 13. doi: 10.1038/s41591-022-02164.
   PubMed        
   
   
8. GENCHI A, Brambilla E, Sangalli F, Radaelli M, et al
   Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.
   Nat Med. 2023 Jan 9. doi: 10.1038/s41591-022-02097.
   PubMed         Abstract available
   
   

   
   Nat Rev Neurol

9. KIANI L
   Serum NfL as an MS biomarker.
   Nat Rev Neurol. 2023;19:3.
   PubMed        
   
   
10. KIANI L
    Cholesterol pathway associated with MS disability.
    Nat Rev Neurol. 2023;19:3.
    PubMed        
    
    

    
    Neurology

11. HORTON MK, Robinson SC, Shao X, Quach H, et al
    A Cross-Trait, Mendelian Randomization Study to Investigate Whether Migraine Is a Risk Factor for Multiple Sclerosis.
    Neurology. 2023 Jan 11:10.1212/WNL.0000000000206791.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

12. BOURRE B, Casez O, Ciron J, Gueguen A, et al
    Paradigm shifts in multiple sclerosis management: Implications for daily clinical practice.
    Rev Neurol (Paris). 2023 Jan 6:S0035-3787(22)00819.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: